US Exchange Filings

Cryo-Cell International Stockholders Re-Elect Directors, Approve Auditor and Executive Compensation

Cryo-Cell International shareholders re-elected all four directors and approved WIPFLI LLC as auditor, along with an advisory vote supporting executive compensation. The results preserve the board lineup and signal investor backing for the company’s oversight and pay practices.

Cryo-Cell International stockholders re-elected four directors and approved the company’s auditor and executive compensation at the annual meeting held October 27. They also approved a measure authorizing proxies to vote on other business that might properly come before the meeting.

  • Director elections: David Portnoy received 6,474,964 votes in favor and 1,215,273 withhold votes; Mark Portnoy received 6,496,862 in favor and 1,193,375 withhold votes. Harold Berger received 7,121,908 in favor and 568,329 withhold votes, while Daniel Mizrahi received 7,152,068 in favor and 538,169 withhold votes. All four were elected.
  • Auditor: Stockholders ratified WIPFLI LLC’s appointment as the company’s independent accounting firm for the fiscal year ending November 30, 2026. The vote was 7,578,019 in favor, 4,178 against and 108,040 abstentions.
  • Executive compensation: The advisory resolution supporting compensation for named executive officers passed, with 6,661,012 votes in favor, 1,028,359 against and 866 abstentions. The vote is non-binding.
  • Other business: Stockholders approved authorizing proxies to vote on other business properly raised at the meeting or any adjournment, with 6,513,018 votes in favor, 515,442 against and 661,777 abstentions.

The results leave the board’s four director seats with the candidates listed above and confirm stockholder approval of the auditor and executive-pay resolution.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.